Prevalence of fatty liver disease in patients with inflammatory bowel disease: a transient elastography study on the basis of a controlled attenuation parameter

Haluk Tarik KANI; İlknur DELIKTAS; Yusuf YILMAZ

doi:https://doi.org/10.5472/marumj.570907

Makale detayları

Prevalence of fatty liver disease in patients with inflammatory bowel disease: a transient elastography study on the basis of a controlled attenuation parameter

Yazarlar:

Haluk Tarik KANI | İlknur DELIKTAS | Yusuf YILMAZ

Yayıncı:

Marmara University

Ana Başlıklar:

Hastalıklar

Dergi:

Marmara Medical Journal 2019 Vol.32 Issue 2, pp.68-70

Belge Tipi:

Makale

Yayın Tarihi:

5/2019

Belge Dili:

İngilizce

Document ID (Org No.):

2000544348

Sıklık:

Aylık

eISSN:

1309-9469

pISSN:

1019-1941

DOI:

https://doi.org/10.5472/marumj.570907

Özet:

 

Objective: Inflammatory bowel disease (IBD) is a chronic
recurrent inflammatory disorder of the gastrointestinal tract
which has an unknown etiology. In this study, we aimed to
investigate the fatty liver disease frequency in IBD patients
using transient elastography (TE) which is a non-invasive and
accurate method for the diagnosis of liver fibrosis.
Material and Methods: The data were collected from
registered patients retrospectively. On the basis of previous
studies, a cut-off value of 238 dB/m for controlled attenuation
parameter (CAP) was used for the diagnosis of hepatic steatosis.
In this study we have also settled CAP value above 238 dB/m
as fatty liver.
Results: A total of 99 patients were enrolled in the study.
Mean age was 45.59 ± 11.72 years and 41 (41.4%) patients were
female. Fifty-eight patients (58.6%) had Crohn’s disease, 39
(39.4%) had ulcerative colitis and 2 (2.0%) had indeterminate
colitis. In 8 (8.1%) patients extra-large probe and in 91 (91.9%)
patients medium probe was used to detect liver steatosis. Fatty
liver disease was detected in 44 (44.4%) patients with IBD.
Conclusion: Despite the nutrition disorders in IBD,
fatty liver disease was seen in 44.4% of patients in our
cohort. However, fatty liver disease may be seen without any
aminotransferase elevation in IBD patients. Therefore, liver
steatosis should always be kept in mind and careful attention
should be paid during follow-up of patients with IBD in our
daily practice.

Makale detayları

Prevalence of fatty liver disease in patients with inflammatory bowel disease: a transient elastography study on the basis of a controlled attenuation parameter

Yazarlar: Haluk Tarik KANI | İlknur DELIKTAS | Yusuf YILMAZ

Yayıncı: Marmara University

Ana Başlıklar: Hastalıklar

Dergi: Marmara Medical Journal 2019 Vol.32 Issue 2, pp.68-70

Belge Tipi: Makale

Yayın Tarihi: 5/2019

Belge Dili: İngilizce

Document ID (Org No.): 2000544348

Sıklık: Aylık

eISSN: 1309-9469

pISSN: 1019-1941

DOI: https://doi.org/10.5472/marumj.570907

Sayı

Yazarlar:

Haluk Tarik KANI | İlknur DELIKTAS | Yusuf YILMAZ

Yayıncı:

Marmara University

Ana Başlıklar:

Hastalıklar

Dergi:

Marmara Medical Journal 2019 Vol.32 Issue 2, pp.68-70

Belge Tipi:

Makale

Yayın Tarihi:

5/2019

Belge Dili:

İngilizce

Document ID (Org No.):

2000544348

Sıklık:

Aylık

eISSN:

1309-9469

pISSN:

1019-1941

DOI:

https://doi.org/10.5472/marumj.570907